Literature DB >> 32540992

Upregulation of Multiple CD8+ T Cell Exhaustion Pathways Is Associated with Recurrent Ocular Herpes Simplex Virus Type 1 Infection.

Pierre-Grégoire Coulon1, Soumyabrata Roy1, Swayam Prakash1, Ruchi Srivastava1, Nisha Dhanushkodi1, Stephanie Salazar1, Cassandra Amezquita1, Lan Nguyen1, Hawa Vahed1, Angela M Nguyen1, Wasay R Warsi1, Caitlin Ye1, Edgar A Carlos-Cruz1, Uyen T Mai1, Lbachir BenMohamed2,3,4.   

Abstract

A large proportion of the world's population harbors latent HSV type 1 (HSV-1). Cross-talk between antiviral CD8+ T cells and HSV-1 appear to control latency/reactivation cycles. We found that compared with healthy asymptomatic individuals, in symptomatic (SYMP) patients, the CD8+ T cells with the same HLA-A*0201-restricted HSV-1 epitope specificities expressed multiple genes and proteins associated to major T cell exhaustion pathways and were dysfunctional. Blockade of immune checkpoints with anti-LAG-3 and anti-PD-1 antagonist mAbs synergistically restored the frequency and function of antiviral CD8+ T cells, both 1) ex vivo, in SYMP individuals and SYMP HLA-A*0201 transgenic mice; and 2) in vivo in HSV-1-infected SYMP HLA-A*0201 transgenic mice. This was associated with a significant reduction in virus reactivation and recurrent ocular herpetic disease. These findings confirm antiviral CD8+ T cell exhaustion during SYMP herpes infection and pave the way to targeting immune checkpoints to combat recurrent ocular herpes.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32540992      PMCID: PMC7343593          DOI: 10.4049/jimmunol.2000131

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  99 in total

Review 1.  T cell exhaustion.

Authors:  E John Wherry
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

2.  The herpes simplex virus 1 latency-associated transcript promotes functional exhaustion of virus-specific CD8+ T cells in latently infected trigeminal ganglia: a novel immune evasion mechanism.

Authors:  Aziz A Chentoufi; Elizabeth Kritzer; Michael V Tran; Gargi Dasgupta; Chang Hyun Lim; David C Yu; Rasha E Afifi; Xianzhi Jiang; Dale Carpenter; Nelson Osorio; Chinhui Hsiang; Anthony B Nesburn; Steven L Wechsler; Lbachir BenMohamed
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

3.  Delayed but not early glucocorticoid treatment protects the host during experimental herpes simplex virus encephalitis in mice.

Authors:  Yan Sergerie; Guy Boivin; David Gosselin; Serge Rivest
Journal:  J Infect Dis       Date:  2007-02-07       Impact factor: 5.226

4.  Critical Role of Regulatory T Cells in the Latency and Stress-Induced Reactivation of HSV-1.

Authors:  Wencong Yu; Shuang Geng; Yuanzhen Suo; Xunbin Wei; Qiliang Cai; Bing Wu; Xian Zhou; Yan Shi; Bin Wang
Journal:  Cell Rep       Date:  2018-11-27       Impact factor: 9.423

5.  Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia.

Authors:  Kamal M Khanna; Robert H Bonneau; Paul R Kinchington; Robert L Hendricks
Journal:  Immunity       Date:  2003-05       Impact factor: 31.745

6.  Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia.

Authors:  Georges M G M Verjans; Rogier Q Hintzen; Jessica M van Dun; Angelique Poot; Johannes C Milikan; Jon D Laman; Anton W Langerak; Paul R Kinchington; Albert D M E Osterhaus
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

7.  Blockade of PD-1 and LAG-3 Immune Checkpoints Combined with Vaccination Restores the Function of Antiviral Tissue-Resident CD8+ TRM Cells and Reduces Ocular Herpes Simplex Infection and Disease in HLA Transgenic Rabbits.

Authors:  Soumyabrata Roy; Pierre-Gregoire Coulon; Swayam Prakash; Ruchi Srivastava; Roger Geertsema; Nisha Dhanushkodi; Cynthia Lam; Vivianna Nguyen; Elyssa Gorospe; Angela M Nguyen; Stephanie Salazar; Nuha I Alomari; Wasay R Warsi; Lbachir BenMohamed
Journal:  J Virol       Date:  2019-08-28       Impact factor: 6.549

8.  4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors.

Authors:  Adrienne H Long; Waleed M Haso; Jack F Shern; Kelsey M Wanhainen; Meera Murgai; Maria Ingaramo; Jillian P Smith; Alec J Walker; M Eric Kohler; Vikas R Venkateshwara; Rosandra N Kaplan; George H Patterson; Terry J Fry; Rimas J Orentas; Crystal L Mackall
Journal:  Nat Med       Date:  2015-05-04       Impact factor: 53.440

9.  Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection.

Authors:  Shawn D Blackburn; Haina Shin; W Nicholas Haining; Tao Zou; Creg J Workman; Antonio Polley; Michael R Betts; Gordon J Freeman; Dario A A Vignali; E John Wherry
Journal:  Nat Immunol       Date:  2008-11-30       Impact factor: 25.606

10.  Lytic gene expression is frequent in HSV-1 latent infection and correlates with the engagement of a cell-intrinsic transcriptional response.

Authors:  Joel Z Ma; Tiffany A Russell; Tim Spelman; Francis R Carbone; David C Tscharke
Journal:  PLoS Pathog       Date:  2014-07-24       Impact factor: 6.823

View more
  3 in total

1.  Antiviral CD19+CD27+ Memory B Cells Are Associated with Protection from Recurrent Asymptomatic Ocular Herpesvirus Infection.

Authors:  Nisha R Dhanushkodi; Swayam Prakash; Ruchi Srivastava; Pierre-Gregoire A Coulon; Danielle Arellano; Rayomand V Kapadia; Raian Fahim; Berfin Suzer; Leila Jamal; Hawa Vahed; Lbachir BenMohamed
Journal:  J Virol       Date:  2022-01-05       Impact factor: 6.549

Review 2.  A Comparison of Pseudorabies Virus Latency to Other α-Herpesvirinae Subfamily Members.

Authors:  Jing Chen; Gang Li; Chao Wan; Yixuan Li; Lianci Peng; Rendong Fang; Yuanyi Peng; Chao Ye
Journal:  Viruses       Date:  2022-06-24       Impact factor: 5.818

Review 3.  Local Immune Control of Latent Herpes Simplex Virus Type 1 in Ganglia of Mice and Man.

Authors:  Anthony J St Leger; David M Koelle; Paul R Kinchington; Georges Michel G M Verjans
Journal:  Front Immunol       Date:  2021-09-15       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.